NIPTIFY NIPT Testing

NIPTify NIPT testing is a highly accurate non-invasive prenatal screening test that analyses cell-free fetal DNA circulating in maternal blood to detect common chromosomal abnormalities. The test screens for Down’s syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13) with high detection rates. Unlike diagnostic procedures such as amniocentesis, NIPTify NIPT requires only a simple blood draw. It carries no risk of miscarriage, making it an ideal first-line screening option for expectant parents.

The test works by detecting fragments of fetal DNA that naturally cross the placental barrier into maternal circulation from around 9 weeks of pregnancy. Advanced laboratory analysis can distinguish between maternal and fetal DNA sequences, identifying chromosomal imbalances that indicate conditions like Down’s syndrome. NIPTify NIPT also provides accurate reliable fetal sex determination for parents who wish to know their baby’s gender. Results are typically available within 2-5 working days, and the test has very low false positive rates for the main trisomies, providing reliable screening information for pregnancy management and decision-making.

NIPTify NIPT testing is recommended for all pregnancies from 10 weeks gestation, particularly for women who want early, accurate screening for common chromosomal conditions without the risks associated with invasive diagnostic procedures. The test is especially valuable for pregnancies where maternal age increases the risk of chromosomal abnormalities, or where there is a family history of genetic conditions. Unlike traditional screening methods that combine multiple markers and ultrasound measurements, NIPTify NIPT provides direct analysis of fetal DNA, offering superior accuracy and earlier results than conventional screening approaches.

At London Pregnancy Clinic, we recommend NIPTify NIPT testing as part of comprehensive first-trimester screening, ideally combined with our expert 10-week structural anomaly scan. This combination provides both chromosomal and structural assessment, identifying the majority of significant fetal conditions that can be detected in early pregnancy. The test is particularly beneficial for patients who have experienced previous pregnancy complications, have abnormal early pregnancy screening results, or simply want the reassurance that comes from highly accurate, early genetic screening. Our genetic counselling services help patients understand their results and make informed decisions about ongoing pregnancy care.

NIPTify NIPT testing differs from other NIPT options through its specific laboratory methodology and performance characteristics, though all high-quality NIPT tests analyse cell-free fetal DNA in maternal blood for chromosomal screening. At London Pregnancy Clinic, we offer several NIPT options including PrenatalSafe, Unity, Panorama, and the comprehensive SMART TEST®-KNOVA, each with different coverage and capabilities. NIPTify NIPT focuses on providing highly accurate screening for the three main trisomies with rapid turnaround times and low failure rates, making it an excellent choice for patients seeking reliable basic chromosomal screening.

The key advantages of NIPTify NIPT include its streamlined testing process, consistent performance across different pregnancy types including those with vanishing twin syndrome, and excellent laboratory quality control. While some NIPT options offer expanded screening for microdeletions, sex chromosome abnormalities, or rare genetic conditions, NIPTify NIPT concentrates on delivering exceptional accuracy for the most common and clinically significant chromosomal conditions. Our specialists can discuss which NIPT option best suits your individual needs, pregnancy circumstances, and screening preferences, ensuring you receive the most appropriate testing for your situation.

NIPTify NIPT testing results are typically available within 2-5 working days after your blood sample reaches the laboratory, making it one of the faster NIPT options available. The test has a low redraw rate and low no-call rate, meaning most patients receive definitive results on their first sample without need for repeat testing. Results are provided as either ‘low risk’ or ‘high risk’ for each condition screened, along with specific risk calculations and detailed explanatory information to help you understand the implications.

If NIPTify NIPT indicates high risk for a chromosomal condition, this does not provide a definitive diagnosis but indicates increased likelihood that your baby may be affected. Diagnostic testing through amniocentesis or chorionic villus sampling would be recommended to confirm the findings. Our genetic counsellors provide comprehensive explanation of results, discuss the positive predictive value based on your age and pregnancy factors, and guide you through next steps if further testing is indicated. Low-risk results provide strong reassurance, but cannot completely eliminate the possibility of chromosomal abnormalities, particularly for conditions not covered by the specific NIPTify NIPT panel.

The NIPTify NIPT testing procedure is straightforward and requires only a simple blood draw, similar to routine pregnancy blood tests. No special preparation is needed before your appointment, and the test can be performed at any time of day. Our trained phlebotomists will collect one tube of blood from your arm, which contains sufficient maternal blood for fetal DNA analysis. The entire collection process takes just a few minutes and is completely safe for both mother and baby, with no risk of pregnancy complications or miscarriage.

At London Pregnancy Clinic, NIPTify NIPT testing is often combined with your 10-week pregnancy scan appointment for convenience and comprehensive early pregnancy assessment. After blood collection, your sample is sent to our partner laboratory where advanced genetic analysis techniques isolate and analyse fetal DNA fragments. The laboratory uses sophisticated sequencing technology to count chromosomal material and identify any imbalances indicative of trisomy conditions. You can continue with normal activities immediately after the blood draw, and we will contact you as soon as results are available, typically within 2-5 working days of sample collection.

NIPTify NIPT testing provides screening information rather than diagnostic confirmation, meaning that high-risk results require further diagnostic testing for definitive answers. Diagnostic procedures such as amniocentesis or chorionic villus sampling (CVS) can provide chromosomal analysis of fetal cells, offering 99% accuracy for diagnosing chromosomal conditions like Down’s syndrome. While these diagnostic tests carry a small risk of miscarriage, they provide definitive genetic information that screening tests cannot match.

The choice between screening and diagnostic testing depends on individual circumstances, risk tolerance, and pregnancy management preferences. Many patients prefer to start with NIPTify NIPT screening due to its safety and high accuracy, reserving diagnostic testing only if screening indicates increased risk. Our genetic counsellors help patients understand the differences between screening and diagnostic options, discuss the implications of different test results, and support decision-making about further testing if needed. For patients at higher risk or those requiring definitive genetic information, we can arrange diagnostic procedures with experienced fetal medicine specialists.